SYSTEMATIC SURGICAL CLOSURE OF PATENT FORAMEN OVALE IN SELECTED PATIENTS WITH CEREBROVASCULAR EVENTS DUE TO PARADOXICAL EMBOLISM - EARLY RESULTS OF A PRELIMINARY-STUDY
P. Ruchat et al., SYSTEMATIC SURGICAL CLOSURE OF PATENT FORAMEN OVALE IN SELECTED PATIENTS WITH CEREBROVASCULAR EVENTS DUE TO PARADOXICAL EMBOLISM - EARLY RESULTS OF A PRELIMINARY-STUDY, European journal of cardio-thoracic surgery, 11(5), 1997, pp. 824-827
Objective: To define therapeutic strategy for management of patients w
ith ischemic stroke due to a high probability of paradoxical embolism
through a Patent Foramen Ovale (PFO). Methods: Since 1988 all consecut
ive patients with cerebrovascular events and PFO from the Stroke Regis
try of our population-based primary-care center are prospectively stud
ied and followed; Since 1992, among 118 patients with cryptogenic embo
lic brain infarct or transient ischemic attack (TIA) and PFO, 32 conse
cutive patients younger than 60 years who presented at least two of th
e following criteria were admitted for surgery: history of Valsalva st
rain before stroke (11); multiple clinical events (13); multiple infar
cts on brain Magnetic Resonnance Imaging (MRI) (15); atrial septal ane
urysm (ASA) (16); large right-to-left shunt (> 50 microbubbles) (12).
Results: Operative time 135' +/- 33'. CPB time 34' +/- 14'. Aortic cro
ssclamping time 16' +/- 6'. Post-operative bleeding 485 +/- 170 mi. No
homologous blood transfusion required. No neurological, cardiac or re
nal complications. All patients were followed-up corresponding to a cu
mulative time of 601 patient-months. This revealed no reccurent vascul
ar events nor silent new brain lesions on brain MRI. Systematic simult
aneous contrast Trans Esophageal Echocardiography (TEE)-Trans Cranial
Doppler showed a small residual interatrial shunt in two patients. Con
clusion: Surgical closure of a patent foramen ovale can be accomplishe
d with very low morbidity and reduce efficently the risk of stroke rec
urrence. It seems to be the option of choice in selected patients with
a higher (> 1.5%/ year) risk of stroke recurrence. (C) 1997 Elsevier
Science B.V.